ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 229

$706K Total Retail Price of All Prescriptions

Rank: 21 out of 229

599 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 670 595 1 1
SIMVASTATIN 450 404 2 3
LISINOPRIL 420 366 3 2
HYDROCODONE-ACETAMINOPHEN 315 203 S3 4 7
AMLODIPINE BESYLATE 291 260 5 5
ZOLPIDEM TARTRATE 266 192 6 20
LOSARTAN POTASSIUM 226 209 7 12
ATORVASTATIN CALCIUM 199 175 8 15
GABAPENTIN 196 133 9 10
SERTRALINE HCL 187 147 10 22
METFORMIN HCL 173 141 11 6
OXYCODONE HCL 172 50 S2 12 37
HYDROCHLOROTHIAZIDE 166 140 13 9
OMEPRAZOLE 162 140 14 4
TRIAMTERENE-HCTZ 152 141 15 51
FLUOXETINE HCL 150 127 16 41
FUROSEMIDE 143 119 17 8
LOVASTATIN 138 117 18 11
METOPROLOL SUCCINATE 136 104 19 16
METOPROLOL TARTRATE 131 109 20 13
DONEPEZIL HCL 121 121 21 29
FLUTICASONE PROPIONATE 120 101 22 23
ALENDRONATE SODIUM 119 102 23 14
NAMENDA 119 119 23 39
FELODIPINE ER 116 107 25 61
POTASSIUM CHLORIDE 115 102 26 18
LOSARTAN-HYDROCHLOROTHIAZIDE 106 97 27 65
CRESTOR 101 100 28 30
ATENOLOL 99 92 29 19
ALLOPURINOL 97 80 30 27
SYNTHROID 94 93 31 46
TRAZODONE HCL 93 54 32 34
OXYCONTIN 92 41 S2 33 88
CARVEDILOL 91 75 34 31
CELEBREX 90 87 35 71
SPIRONOLACTONE 85 63 36 56
PANTOPRAZOLE SODIUM 84 56 37 33
SUMATRIPTAN SUCCINATE 83 37 38 246
PRAVASTATIN SODIUM 82 79 39 25
RANITIDINE HCL 76 75 40 32
ADVAIR DISKUS 71 57 41 47
MORPHINE SULFATE ER 71 18 S2 41 70
TRAMADOL HCL 67 59 43 26
ZETIA 64 53 44 93
PROPRANOLOL HCL 62 26 45 127
BUPROPION XL 62 44 45 209
NEXIUM 60 45 47 48
BACLOFEN 60 16 47 107
AMITRIPTYLINE HCL 59 27 R 49 66
LEVOTHROID 59 55 49 130
PROAIR HFA 58 46 51 38
OXYBUTYNIN CHLORIDE 57 53 52 97
ENDOCET 57 14 S2 52 135
LANTUS 57 39 52 40
VENLAFAXINE HCL ER 56 43 55 122
OXYCODONE-ACETAMINOPHEN 56 24 S2 55 43
CIPROFLOXACIN HCL 55 45 57 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 50 57 28
WARFARIN SODIUM 55 55 57 17
TRIAMCINOLONE ACETONIDE 54 53 60 113
ENALAPRIL MALEATE 54 54 60 54
PREMARIN 50 50 R 62 101
AZITHROMYCIN 50 38 62 53
MIRTAZAPINE 50 23 62 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.